Glasgow headquartered EnteroBiotix Limited, a clinical stage biopharmaceutical company with the premier platform for full─spectrum microbiome therapeutics, has strengthened its executive team by appointing two key executives Dr James Barnes as Chief Operating Officer (COO) and Chris Lea as Chief Financial Officer (CFO).
EnteroBiotix is a Scotland-based biotechnology company that researches and develops novel microbiome-modulating therapeutics for the treatment of bacterial infections.